European Injectable Drug Delivery Market Worth $12.4 Billion by 2017
DALLAS, July 2, 2013 /PRNewswire/ --
The report "European Injectable Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Forecasts to 2017" analyzes and studies the major market drivers, restraints, and opportunities in Germany, France, U.K., Spain, Italy, Russia and Rest of Europe (RoE).
- 143 Market data tables
- 25 Figures
- 333 Pages and an in-depth Table of Contents on "European Injectable Drug Delivery Market"
Early buyers will receive 10% customization on this report.
The European Injectable Drug Delivery Technologies Market was valued at $6.8 billion in 2012; it is expected to reach $12.4 billion by 2017 at a CAGR of 12.7% from 2012 to 2017. The Injectable Drug Delivery Technologies Market is broadly categorized into two major segments, namely,
- Devices Technologies
- Formulation Technologies
Based on Product, the Injectable Drug Delivery Devices Technologies Market is further categorized as:
- Conventional Injection Devices
- Self Injection Devices
- Others (Microneedles, Nanoneedles and Blunt Needle Injections)
While the Injectable Drug Delivery Formulation Technologies Market is categorized into:
- Conventional Drug Delivery Formulations
- Novel Drug Delivery Formulations
The conventional injection devices segment accounted for the largest share of the European injectable drug delivery technologies market in 2012.
The growth of the European Injectable Drug Delivery Market is primarily triggered by favorable reimbursement policies on injectable drugs and devices, technological advancements, surge of biologics in pharmaceutical markets, rising incidences of cancer and diabetes in Europe, and improving patient compliance. The evolving opportunities in this market for manufacturers include development of biosimilars in pharmaceutical markets and focus of pharmaceutical manufacturers towards emerging markets such as Spain, Russia, Denmark, Ireland and others. However, factors such as needle-stick injuries and infections and development of alternate delivery methods are restraining the growth of the market.
The Major Geographic Markets covered in this Report are:
- North Germany
- Russia and Rest of Europe (RoE)
Germany dominates the market, followed by France. The other European regions of Spain, Italy and Russia and RoE show high export potential for plastic syringes and needles, favorable reimbursement policies for injectable devices, rising support for generics market and increasing expenditure in healthcare sector, favorable environment for research and development, and growth in diabetic expenditures.
The Key Players in this Market are:
- Becton Dickinson & Co. (U.S.)
- Baxter International, Inc. (U.S.)
- Novo Nordisk A/S (Denmark)
- Ypsomed Holding AG (Switzerland)
- Eli Lily & Co. (U.S.)
- Gerresheimer AG (Germany)
- Sanofi (France)
- West Pharmaceutical Services, Inc. (U.S.)
- Haselmeier GmbH (Germany)
- Owen Mumford, Ltd. (U.K.) and others
Buy a copy of this Report @ http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=1205
Browse Related Reports to Injectable Drug Delivery Market
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductors and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
More by this Source
Magnetic Resonance Imaging (MRI) System Market worth $5.24 Billion By 2018
Dec 19, 2013, 08:30 ET
Virtual Reality & Augmented Reality Market Worth 1.06 Billion by 2018
Dec 18, 2013, 09:30 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.